The hospital-acquired infection control market is expected to grow at a CAGR of 2.07% during the forecast period (2022-2027). Europe is the second-largest market for HAI control in 2021. Germany, France, Italy, UK and Spain are the major revenue contributor to this region.
The prevalence of healthcare-associated infections (HAIs) across healthcare settings and the subsequent rise in demand for disinfection and sanitization products to control the spread of these infections contribute to the market growth. The market is also growing due to increasing awareness among healthcare practitioners (HCPs) and patients regarding advanced disinfectants and sterilizers and the availability of several effective healthcare disinfectants and sterilizers.
MARKET GROWTH ENABLERS
Increased Use of Ethylene Oxide Sterilization
High Incidences of HAIS
Stringent Government Regulations
The disinfection segment is accounted for a major share in 2021. The rising awareness and knowledge among the end-user have further increased the adoption of advanced HAI control products, hence boosting the market growth. The hospital & clinics segment is dominating the global market and is witnessing steady growth in the forecasted period as hospitals & clinics are the first points of care source to get tested and treated for any disease than other healthcare settings.
Contact: [email protected]
Global Information, Inc. [JASDAQ 4171] https://www.giiresearch.com/ Toll Free (US): +1-866-353-3335 Outside US: +1-860-674-8796 Europe (Belgium): +32-2-535-7543 Email: [email protected]